[144] Magnite, Inc. SEC Filing
Magnite, Inc. (MGNI) filing a Form 144 notifies the market that 27,671 shares of common stock held by the selling person will be offered for sale through Morgan Stanley Smith Barney LLC on 09/04/2025 on NASDAQ. The filing reports an aggregate market value of $683,849.80 based on the planned sale and notes total shares outstanding of 142,399,305. The shares were acquired as restricted stock from the issuer on 08/15/2022. The filer also reported a recent sale of 2,961 shares on 08/18/2025 for $70,629.62. The notice includes the standard representation that the seller is not aware of any undisclosed material adverse information.
- Full disclosure of planned sale details including broker, sale date, share count, and aggregate value
- Securities were acquired as restricted stock and acquisition date is clearly stated (08/15/2022), supporting Rule 144 eligibility
- Recent prior sale disclosed (2,961 shares on 08/18/2025 for $70,629.62), improving transparency about insider activity
- Insider selling of 27,671 shares may be perceived negatively by some investors despite being small relative to outstanding shares
- No 10b5-1 plan date provided, so the filing does not indicate whether sales follow a pre-established trading plan
Insights
TL;DR: Insider plans to sell 27,671 restricted shares via Morgan Stanley; transaction size is modest relative to shares outstanding.
The Form 144 discloses a proposed sale of 27,671 common shares with an aggregate market value of $683,849.80, representing a small fraction of the reported 142.4 million shares outstanding. The securities were originally issued as restricted stock on 08/15/2022 and are being brokered through a major dealer, which supports orderly execution. The recent prior sale of 2,961 shares for $70,629.62 indicates prior partial liquidation activity. From a market-impact perspective, the disclosed sale size is unlikely to materially affect share supply or valuation given Magnite’s share count.
TL;DR: Filing meets Rule 144 disclosure requirements and includes the required insider certification about material information.
The notice provides required details: acquisition date (08/15/2022), nature of acquisition (restricted stock), broker identification, intended sale date (09/04/2025), and prior sales within three months. The signature representation affirms absence of undisclosed material adverse information, and the filing identifies the broker and recent transaction history, supporting transparency and regulatory compliance. No indications of confidentiality waivers, 10b5-1 plan adoption date, or other exemptions are included in the filing.